The intraocular lens market is highly competitive; thus, key players need to upgrade their products to up to date with the latest technologies. Hence, product development (product launch & approval) is the key developmental strategy adopted by major players to sustain the competitive environment. These players focus on new product launches & approvals to commercialize their products with new advanced features, thus offering innovations in this market. In this regard, in October 2015, Alcon received FDA approval for AcrySof IQ Aspheric IOL with the UltraSertTM Pre-loaded Delivery System for patients undergoing cataract surgery. Moreover, new product launches facilitate companies to increase their market share to survive the competitive intraocular lens market. For instance, in May 2017, STAAR Surgical received CE approval for the commercial distribution of EVO+ Visian ICL with Aspheric (EDOF) Optic in Europe. This product approval helped the company to expand its portfolio for the treatment of hyperopia and myopia between +3.0 diopters and −18.0 diopters.

CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

CHAPTER 4 INTRAOCULAR LENS MARKET, BY TYPE

CHAPTER 5 INTRAOCULAR LENS MARKET, BY END USER

CHAPTER 6 INTRAOCULAR LENS MARKET, BY MATERIAL

CHAPTER 7 INTRAOCULAR LENS MARKET, BY REGION

CHAPTER 8 COMPANY PROFILES